Tahara, Makoto http://orcid.org/0000-0001-9035-3106
Kiyota, Naomi
Nibu, Ken-ichi
Akamatsu, Ayumi
Hoshino, Tomohiro
Hayashi, Ryuichi
Funding for this research was provided by:
Ono Pharmaceutical Co., Ltd.,
Bristol-Myers Squibb K.K.
Article History
Received: 6 April 2021
Accepted: 25 May 2021
First Online: 10 June 2021
Declarations
:
: M.T. received research funding from AstraZeneca, MSD, Ono, Bayer, and Pfizer; and honoraria from Ono and Bristol-Myers Squibb. N.K. received research funding from Ono, Bristol-Meyers Squib, Chugai-Roche, AstraZeneca, Pfizer, and Rakuten Medical; and honoraria from Ono, Bristol-Meyers Squib, MSD, Merck Biopharma, Chugai, and Bayer. K.N. declared no competing interest. A.A. is an employee and a stockholder of Ono. T.H. is an employee of Ono. R.H. serves in an advisory role in Rakuten Medical.